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Percutaneous transluminal coronary angioplasty is an 
accepted treatment for selected patients with single ves•
sel disease but has not been rigorously evaluated in pa•
tients with double vessel disease. Among 769 patients 
undergoing transluminal coronary angioplasty between 
1980 and 1984, 74 with double vessel stenosis of 50% or 
more underwent double vessel coronary angioplasty. 
Primary success was obtained for both lesions in 63 pa•
tients (85%), for one lesion in 11 patients (15%) and for 
137 (93%) of 148 segments overall. Except for myo•
cardial infarction in one patient, no serious complication 
occurred. Before coronary angioplasty, 15 patients had 
unstable angina, 14 had Canadian Cardiovascular So•
ciety class III and 32 class I to II effort angina and only 
2 were asymptomatic. Six months after coronary angio•
plasty, 27 were asymptomatic, 27 had class I to II and 
5 had class III effort angina and 2 had sustained an 
episode of unstable angina. During the foilow-up study, 
two patients had an Infarction and one had coronary 
artery bypass surgery. 
Transluminal coronary angioplasty experience has been ac•
cumulated primarily in patients with single vessel coronary 
artery disease, for whom this procedure is now widely ac•
cepted as an alternative treatment. More recently, some 
centers (I) have enrolled an increasing number of patients 
with multivessel disease. This broader use has significantly 
increased the impact of the procedure because it has been 
estimated that less than 15% of patients undergoing coronary 
artery bypass surgery would fulfill the criteria for single 
vessel coronary angioplasty (2,3). 
The success rate in patients with multiple dilations is 
comparable with that seen in patients with single vessel 
disease; the rate of complications is also similar (4-14). 
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Coronary arteriography was performed at a mean of 
5.5 ± 2.1 months after coronary angioplasty in all but 
three patients. Restenosis was found in 30 (23%) of 132 
segments with angiographic control. Restenosis was 
present .in one vessel in 17 patients and in both vessels 
in 4; 40 patients (66%) had no restenosis. Of the 34 
patients with definite or probable angina, 50% had re•
stenosis and 19% of patients with restenosis were symp•
tom free. By stepwise logistic regression analysis, an•
gioplasty site (p = 0.0003), degree of residual stenosis 
(p = 0.001), calcified stenosis (p = 0.01) and bal•
loon/artery diameter ratio (p = 0.02) were retained as 
predictors of restenosis. 
Thus, double transluminal coronary angioplasty can 
be performed in selected patients with double vessel dis•
ease with a high primary success rate and very low in•
cidence of complications although, as expected, the re•
stenosis rate per patient is higher than in single vessel 
coronary angioplasty. 
(J Am Coil CardioI1985;6:1239-44) 
Restenosis remains one of the most difficult problems related 
to coronary angioplasty. The evaluation of restenosis re•
quires that the follow-up angiography rates be high, because 
even though most patients with restenosis are symptomatic, 
about one-fourth do not have either definite or probable 
angina (15). So far there has been very little information 
on the problem of restenosis after multiple dilations because 
of the relatively low percent of patients undergoing follow•
up angiography. This study reports on our primary angio•
graphic success, complications and clinical improvement in 
patients undergoing transluminal coronary angioplasty in 
double vessel disease. The high rate of follow-up angiog•
raphy provides a group of consecutive patients in whom the 
problem of restenosis can be evaluated. 
Methods 
Patients. Between August 1980 and June 1984, a total 
of 769 patients underwent percutaneous transluminal coro-
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nary angioplasty at the Montreal Heart Institute. Coronary 
angioplasty in double vessel disease (50% or greater di•
am\!ter stenosis) was performed in 74 patients; 10 cases were 
undertaken between June 1983 and June 1984. There were 
58 men (78%) and 16 women (22%) whose mean age was 
52 ± 10 years. Sixteen patients (22%) had a previous myo•
cardial infarction (Table 1). The number of vessels with 
50% or greater diameter stenosis was 2.1 ± 0.38 (mean 
± SD) per patient and the number of vessels with 70% or 
greater diameter stenosis was 1.6 ± 0.6 per patient (Table 
2). None of the patients had totally occluded arteries. Of 
the 148 attempted segments, 70 were in the left anterior 
descending, 34 in the left circumflex coronary and 44 in the 
right artery. Fifty-five lesions were in the proximal, 47 in 
the middle and 18 in the distal coronary artery segment. In 
28 cases, the stenosis involved a major branch of a coronary 
artery. The stenosis was eccentric in 83 cases (56%). A 
short or discrete (0.5 cm or less) lesion was found in 86 
segments (58%); 46 lesions (31 %) were tubular (greater than 
1 cm) and 16 (11 %) diffuse (greater than 0.5 cm) (Table 
2). The mean ejection fraction was 61 ± 9%. Patients with 
previous coronary artery bypass surgery were not included 
in this group. All were accepted for and agreeable to bypass 
surgery if this became necessary. 
Coronary angioplasty procedure and adjunctive ther•
apy. All dilated segments were studied prospectively mea•
suring arterial diameter proximal and distal to the stenosis 
to determine the optimal balloon size. The degree of stenosis 
was measured with a caliper in the view showing the most 
severe stenosis at angiography and was expressed as a per•
cent of luminal narrowing as compared with the closest 
normal segment. The configuration of the lesion and the 
characteristics of the vessel were also noted. Data related 
to the procedure were systematically collected using a stan•
dard protocol. 
All coronary angioplasty procedures were performed by 
way of a percutaneous femoral approach using a previously 
described protocol (16), except for the following recent 
modifications. Steerable catheters have been used since April 
Table 1. Baseline Clinical Characteristics of 74 Patients 
No. of patients 
Men 
Women 
Mean age (yr) 
Angina (mo)* 
Previous myocardial infarction 
High blood pressure 
Diabetes 
Cigarette smoking 
Cholesterol (mg/dl)* 
Low density lipoproteins* 
High density lipoproteins* 
*Values are mean ± SO. 
74 
58 
16 
52 
19 ± 29 
16 (22%) 
17 (23%) 
6 (8%) 
40 (54%) 
239 ± 55 
45 ± 18 
148 ± 58 
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Table 2. Baseline Angiographic Characteristics of 74 Patients 
With 148 Coronary Artery Stenoses 
No. of vessels with 50% or greater stenosis 
No. of vessels with 70% or greater stenosis 
Stenotic coronary artery 
Left anterior descending 
Right 
Circumflex 
Geometry of stenosis 
Eccentric 
Concentric 
Morphology of stenosis 
Short 
Tubular 
Diffuse 
Mean stenosis diameter (%)* 
Mean translesional pressure gradient (%)* 
Ejection fraction (%)* 
*AII values are mean ± SO. 
2.1 ± 0.38 
1.6 ± 0.6 
70 
44 
34 
83 (56%) 
65 (44%) 
86 (58%) 
46 (31%) 
16 (11%) 
73 ± 14 
53 ± 14 
61 ± 9 
1982. After April 1983, following our previous experience 
(17), we began using higher inflation pressures (8 to 12 atm) 
and larger balloons with the goal of achieving a ratio of 
1.1: 1.3 (inflated balloon diameter/adjacent healthy coro•
nary segment) which we believe to be optimal (18). Never•
theless, we used smaller balloons to dilate calcified lesions. 
Diltiazem, 60 or 90 mg, was administered the evening 
before and the morning of coronary angioplasty and three 
times daily thereafter for 6 months if the dilation was suc•
cessful. Antiplatelet drugs (aspirin, 650 mg, plus dipy•
ridamole, 225 mg daily) were also prescribed beginning the 
day before cororiary angioplasty and continuing for 6 months. 
Follow-up. All patients were followed up for at least 6 
months, at which time a routine follow-up coronary angio•
gram was performed. Repeat coronary angiography was 
performed promptly in any patient who either redeveloped 
angina or had a deterioration in functional class. The control 
angiogram or coronary artery bypass surgery was considered 
to be the end point of the follow-up study. 
Primary success was defined as a decrease in the degree 
of coronary artery diameter narrowing of 20% or more (19) 
or a residual luminal diameter stenosis of 60% or less on 
the angiogram taken immediately after coronary angio•
plasty. Restenosis was defined as an increase in the degree 
of coronary artery diameter stenosis of 30% or more (19) 
or a luminal diameter stenosis of 70% or more on the follow•
up angiogram. We recognize that none of the angiographic 
definitions of early success or restenosis after coronary an•
gioplasty is universally accet:>ted or is ideal from a clinical 
standpoint. 
Statistical analysis. Univariate analysis was performed 
using the chi-square test for categorical data and the unpaired 
t test for continuous variables. Multivariate analysis was 
performed by means of a stepwise logistic regression anal•
ysis to identify the best set of predictors for restenosis (20). 
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A probability (p) value of less than 0.05 was considered 
significant. 
Results 
Primary success and complications. Primary success 
was obtained for both lesions in 63 patients (85%) and for 
only one lesion in 11 patients (15%). We attempted coronary 
angioplasty in a total of 148 segments: 3 (2%) could not be 
crossed, we were unable to dilate the vessel in 8 cases (5%) 
and there were 137 primary successes (93%). Mean stenosis 
diameter decreased from 73 ± 14 to 31 ± 17% and mean 
translesional pressure gradient decreased from 53 ± 14 to 
14 ± 11 mm Hg. Except for myocardial infarction in one 
patient, there were no serious complications. None of the 
patients went to emergency coronary artery bypass surgery 
and there were no deaths. 
Rate of restenosis. Follow-up coronary angiography was 
performed in 71 (96%) of the 74 patients after a mean of 
5.5 ± 2.1 months. One patient had coronary artery bypass 
surgery 2 weeks after coronary angioplasty because of per•
sistent angina, and two patients were lost to follow-up. Of 
63 patients with primary success in both lesions, 61 (97%) 
had a follow-up angiogram (Group I); restenosis was found 
in 21 patients (34%), 17 of whom had restenosis in one 
segment and 4 in both segments. Follow-up angiograms 
were performed in all II patients with primary success in 
only one segment except the 1 patient having bypass surgery 
(Group II); restenosis was found in 5 (Table 3). Overall, 
132 successfully dilated segments had an angiographic fol•
low-up (96%); restenosis was present in 30 segments (23%). 
Mean stenosis diameter at restudy of the 102 segments that 
did not undergo restenosis was 32 ± 19%. 
Degree of clinical improvement. Group I (61 pa•
tients). At the end of the follow-up study, 23 (58%) of the 
40 patients without restenosis were asymptomatic, 12 (30%) 
had no improvement, 4 (10%) showed deterioration in Ca•
nadian Cardiovascular Society functional class or a recur•
rence of angina and 1 (2%) had a myocardial infarction. 
Four of the latter five patients developed 50% or greater 
Table 3. Angiographic Follow-Up 6 Months After Coronary 
Angioplasty in 74 Patients With Double Vessel Disease 
Primary success for both lesions 
Follow-up angiogram (Group I) 
Restenosis 
In one segment 
In both segments 
Primary success for only one lesion 
Follow-up angiogram (Group II) 
Restenosis 
No. of 
Patients 
63 
61 (97%) 
21 (34%) 
17 
4 
II 
10 (91%) 
5 (45%) 
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Table 4. Clinical Follow-Up at the Time of Repeat 
Angiography 6 Months After Coronary Angioplasty in 71 
Patients With Double Vessel Disease 
Group I (61 patients) 
Asymptomatic at 6 months 
Without restenosis 
With restenosis in one segment 
With restenosis in both segments 
Group II (10 patients) 
Asymptomatic at 6 months 
Without restenosis 
With restenosis 
No. of 
Patients 
27 of 61 (44%) 
23 of 40 (58%) 
4 of 17 (24%) 
o of 4 
2 of 10 (20%) 
2 of 5 (40%) 
o of 5 
Group I = patients with primary success for both lesions who had a 
follow-up angiogram; Group II = patients with primary success for only 
one lesion who had a follow-up angiogram. 
diameter narrowing in new segments on the follow-up an•
giogram. Among the 17 patients with restenosis in one seg•
ment, 3 developed recurrence of angina or a deterioration 
in functional class, 10 remained in the same fun~tional class 
and 4 were asymptomatic. None of the four patients with 
restenosis in both segments had a myocardial infarction, 
two developed recurrence of angina or a deterioration in 
functional class and two remained in class II effort angina. 
Group 11 (10 patients). Among the five patients without 
restenosis on follow-up angiogram, one developed recurrent 
angina, two had no improvement and two were asympto•
matic. Of the five patients with restenosis, one had a myo•
cardial infarction during follow-up and four developed re•
current angina or a deterioration in functional class (Table 
4). 
Effect on angina. Before coronary angioplasty, 15 (25%) 
of the 61 patients in Group I had unstable angina, 13 (21 %) 
Figure 1. Primary success rate for both lesions (61 patients). 
AngIna status before coronary angioplasty and at the end of follow•
up. <?Iass. I-II and class III = Canadian Cardiovascular Society 
claSSificatIOns; PTCA = percutaneous transluminal coronary 
angioplasty. 
" 100 
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BEFORE PTCA 6 MONTHS AFTER PTCA 
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Figure 2. Relation between symptoms and restenosis in 61 patients 
had class III effort angina, 32 (52%) had class I to II angina 
and 1 (2%) had no symptoms; at the end of follow-up, 27 
(44%) were asymptomatic, 27 (44%) had class I to II and 
5 (8%) class III angina and 2 (4%) had sustained an episode 
of unstable angina (Fig. 1). Thirty-four patients (56%) had 
chest pain judged to be definite or probable angina and 27 
(44%) were asymptomatic at the time of follow-up angi•
ography. Restenosis was documented in 17 patients (50%) 
with definite Qr probable angina compared with 4 patients 
(15%) without chest pain (Fig. 2). Among the 21 patients 
with restenosis, 4 (19%) were asymptomatic. The antian•
ginal medication before coronary angioplasty and at the end 
of follow-up is shown in Figure 3. Before coronary angio•
plasty 10 patients had no medication, 10 were receiving 
calcium channel blocking agents, 24 were taking beta-ad•
renergic blocking drugs and 17 were receiving both drugs. 
At the end of the follow-up, 28 had no medication, 21 were 
receiving calcium channel blockers, II were taking beta•
blockers and only 1 patient was receiving both drugs. 
Factors associated with restenosis. We analyzed 39 
Figure 3. Antianginal medication before coronary angioplasty and 
at the end of follow-up (61 patients). PTCA = percutaneous trans•
luminal coronary angioplasty. 
!IIIII BOTH DRUGS 
c=J BETA-BLOCKERS 
urn Ca++ANTAGONISTS 
• NO MEDICATION 
BEFORE PTCA 6 MONTHS AFTER PTCA 
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Table 5. Restenosis-Related Factors in 132 Coronary Segments 
Degree of initial stenosis 
Residual stenosis 
Artery 
Left anterior descending 
Right anterior descending 
Circumflex 
Calcium in stenosis 
Eccentricity of stenosis 
Balloon/artery ratio 
Distal runoff 
Good 
Irregular 
Poor 
p Values 
0.0002 
0.002 
0.016 
0.01 
0.02 
0.02 
0.05 
variables related to baseline clinical data, angiographic char•
acteristics and the angioplasty procedure. Variables asso•
ciated with restenosis in univariate analysis were: degree of 
initial stenosis (p = 0.0002); degree of residual stenosis (p 
= 0.002); angioplasty site, that is, right less than left an•
terior descending or circumflex artery (p = 0.016); calcified 
lesions (p = 0.01); eccentricity of stenosis (p = 0.02); 
balloon/artery ratio (p = 0.02) and distal runoff, that is, 
irregular or poor greater than good (p = 0.05) (Table 5). 
By stepwise logistic regression analysis, angioplasty site, 
that is, right less than left anterior descending or circumflex 
artery (p = 0.00(3), degree of residual stenosis (p = 0.(01), 
calcified stenosis (p = 0.01) and balloon/artery ratio, that 
is, 0.9 greater than 1. 1 (p = 0.02) were retained as pre•
dictors of restenosis (Table 6). 
Discussion 
Coronary angioplasty in multi vessel disease. 
Percutaneous transluminal coronary angioplasty has become 
increasingly accepted as an alternative treatment in patients 
with multivessel coronary artery disease. This technique 
should be evaluated not only for its rate of primary success 
and the risks of the procedure but also for sustained patency 
of the angioplasty site, improvement of signs and symptoms 
of myocardial ischemia and incidence of complications of 
coronary artery disease after coronary angioplasty. 
In agreement with previous reports (4-14), our study 
shows that coronary angioplasty can be performed simul•
taneously in double vessel disease with a high primary suc•
cess rate and a low complication rate similar to that of 
coronary angioplasty in single vessel disease. 
Incidence of restenosis. Investigators are still con•
cerned that a significant number of patients with successful 
dilation may develop restenosis associated with a recurrence 
of myocardial ischemia. The incidence of restenosis after 
multi vessel angioplasty has not been rigorously evaluated. 
lACC Vol. 6, No.6 
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Table 6. Variables Predictive of Restenosis by Stepwise Logistic Regression Analysis 
95% 
Confidence Difference 
p Odds Limits for Odds Associated With 
Variables Entered Chi-Square Value Bi Ratio Ratio Odds Ratio 
Right coronary artery 12.8 0.0003 - 1.119 3.06 1.47 to 6.4 Absence versus 
presence 
Residual stenosis 10.75 0.001 0.059 3.25 2.24 to 4.72 40 versus 20% 
Calcified stenosis 6.66 0.01 0.810 2.25 1.21 to 4.18 Presence versus 
absence 
Balloon/artery 5.4 0.02 -2.116 1.53 0.24 to 9.77 0.9 versus 1.1 
diameter ratio 
Constant a -1.035 
Chi-square values are based on likelihood ratio test and should be compared with one degree of freedom 
chi-square distribution. Bi is the regression coefficient for each variable selected by the model; constant a is 
the constant term of the regression. 
The highest reported rate of follow-up angiography is 65% 
(21 ). 
Routine follow-up angiography in all patients seems to 
be the most valid approach because it avoids any bias in 
selection. A recent report (15) from the National Heart, 
Lung, and Blood Institute percutaneous transluminal coro•
nary angioplasty registry shows that 81 % of the patients 
who underwent follow-up angiography during the first 5 
months after coronary angioplasty had chest pain compared 
with 38% of those who underwent follow-up angiography 
more than 5 months after coronary angioplasty. 
Our study provides a group of 74 patients with a clinical 
and angiographic follow-up rate of 96%. Restenosis was 
present in 50% of the patients with definite or probable 
angina, and 19% of patients with restenosis were asymp•
tomatic. A previous report (15) and our study suggest that 
the clinical status is not a reliable means to detect the pres•
ence of restenosis. The value of exercise stress tests and 
thallium perfusion scans to detect restenosis in this subset 
of patients remains to be determined. 
Predictors of restenosis. The cause of restenosis is not 
known. Baseline clinical characteristics, morphologic fea•
tures and site of the stenosis, procedural factors and med•
ication may all influence the rate of restenosis. None of the 
baseline clinical characteristics (Table I) was significantly 
different in patients with or without restenosis in this study. 
By stepwise logistic regression analysis, the site of angio•
plasty, that is, right less than left anterior descending or 
circumflex artery (p = 0.0003), degree of residual stenosis 
(p = 0.(01), calcified stenosis (p = 0.01) and bal•
loon/artery ratio, that is, 0.9 greater than 1.1 (p = 0.02) 
were retained as predictors of restenosis. 
In a previous report (17) we also retained the degree of 
residual stenosis as an important predictor of restenosis. We 
believe that a high rate of continuous success requires an 
optimal selection of the balloon/artery ratio (18,22) and 
optimal balloon pressure application (23). Our data suggest 
that anatomic or procedural factors could be responsible for 
restenosis. Of 21 patients with restenosis, 17 (81 %) showed 
persistent success in one segment, and restenosis was pres•
ent in both lesions in only 4. 
A major area of interest in patients undergoing coronary 
angioplasty is the use of medication in an attempt to decrease 
restenosis. Our patients received antiplatelet drugs or cal•
cium channel blockers, or both, but our study protocol was 
not designed to strictly monitor timing or compliance to 
medication. 
Timing of follow-up angiography. We have performed 
control coronary angiograms 6 months after coronary an•
gioplasty. According to the National Heart, Lung, and Blood 
Institute percutaneous transluminal coronary angioplasty re•
gistry (15), the incidence of restenosis in patients who 
underwent follow-up angiography was highest within the 
first 5 months after coronary angioplasty. The interval from 
coronary angioplasty to the development of clinical mani•
festations of restenosis in most instances was less than 4 
months (24). The clinical and angiographic assessment 6 
months after coronary angioplasty could also have some 
predictive value because it has been suggested that short•
term success is maintained for at least 2 to 3 years (25,26). 
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